CCO Slideset

Update on Cardiovascular Risk and Antiretroviral Therapy

Source: Managing Cardiovascular Risk in HIV-Infected Patients: The Role of Antiretroviral Selection

Update on Cardiovascular Risk and Antiretroviral Therapy


Faculty:

  • Andrew Carr, MD

CME CREDIT INFORMATION

Release Date: 12/14/07

Expiration Date: 12/13/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review current data on cardiovascular risk factors in HIV-infected patients
  • Describe the recommendations for clinical management of lipids in HIV-infected patients
  • Discuss the role of antiretroviral selection and modification as part of a strategy of lipid management for HIV-infected patients
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.